Cerevel Investors Allege Insider Trades Pre-$8.7B AbbVie Deal <https://www.law360.com/mergersacquisitions/articles/1854879?nl_pk=a34c25b5-f021-4515-a5f9-06e53584a502&utm_source=newsletter&utm_medium=email&utm_campaign=mergersacquisitions&utm_content=2024-07-05&read_main=1&nlsidx=0&nlaidx=2>
By Leslie A. Pappas A pension fund shareholder of Cerevel Therapeutics Holdings Inc. has sued the biopharmaceutical company in Delaware's Court of Chancery, seeking documents to investigate potential fiduciary duty breaches and possible insider trading shortly before the company announced its pending $8.7 billion merger with AbbVie Inc. Read full article » <https://www.law360.com/mergersacquisitions/articles/1854879?nl_pk=a34c25b5-f021-4515-a5f9-06e53584a502&utm_source=newsletter&utm_medium=email&utm_campaign=mergersacquisitions&utm_content=2024-07-05&read_more=1&nlsidx=0&nlaidx=2> | Save to favorites » <https://www.law360.com/mergersacquisitions/articles/1854879?nl_pk=a34c25b5-f021-4515-a5f9-06e53584a502&utm_source=newsletter&utm_medium=email&utm_campaign=mergersacquisitions&utm_content=2024-07-05&read_later=1&nlsidx=0&nlaidx=2>
